Tamtam Try Tamtam free
Johns Hopkins Medicine logo

Johns Hopkins Medicine account plan

medical research teaching patient care

At a glance

Johns Hopkins Medicine's health system runs six hospitals, health plans and pharmacies, with $9,639.1 million of FY2025 operating revenues.

The Johns Hopkins Health System Corporation (JHHS) is the Maryland not-for-profit parent of the Johns Hopkins Medicine clinical enterprise: The Johns Hopkins Hospital in East Baltimore, the Bayview, Howard County, Suburban and Sibley Memorial community hospitals, Johns Hopkins All Children's Hospital in Florida, a physician group, home care, pharmacies and the Johns Hopkins Health Plans. It serves patients primarily in Maryland, the District of Columbia and Florida, while the Johns Hopkins University, a separate legal entity, supplies the physicians and research. In FY2025 (year ended June 30, 2025) total operating revenues and other support were $9,639.1 million (FY2024: $9,047.9 million), income from operations $192.8 million and excess of revenues over expenses $542.5 million. JHHS also centralises shared services such as finance, HR, payroll, purchasing and patient financial services for its affiliates.

Business units

Strategic priorities

Academic medicine with the University
JHHS paid the University $527.7 million for medical services in FY2025 and approved a $62.5 million contribution to the School of Medicine's research and education mission in June 2025.
East Baltimore campus build-out
A medical research building on The Johns Hopkins Hospital campus is opening in phases between 2024 and 2026; JHHS committed up to $70.0 million to School of Medicine research operations in it through fiscal 2029.
Population-based payment in Maryland
Maryland's model fixes each hospital's revenue base annually regardless of volume and patient mix for Maryland residents, under a waiver approved through calendar year 2027.
Growing pharmacy and outpatient revenue
Outpatient pharmacy revenues rose to $786.5 million from $655.7 million and other revenue to $1,377.4 million from $1,214.8 million.
Physician recruitment
JHHS pledged $66.0 million in 2021 for recruiting clinically focused physicians, and the hospital endowment funds start-up packages for department directors and chairs.

Investments and deals

Capital spending
Purchases of property, plant and equipment were $293.1 million in FY2025 (FY2024: $307.9 million), with construction in progress of $202.1 million.
Medical research building
JHH's share of the research building under construction was $92.5 million at June 30, 2025; the University funds 65% of construction costs.
Bond refinancing
In August 2024 JHHS refinanced its Series 2016B, 2018A and 2018B bonds into 2024 Series A, B and C variable rate demand bonds; parity debt was $1.6 billion.

Challenges and risks

Thin operating margin
Operating expenses of $9,446.4 million left income from operations of $192.8 million in FY2025; purchased services ($3,575.9 million) and salaries, wages and benefits ($3,484.6 million) are the biggest costs.
Litigation
The Kowalski verdict against All Children's Hospital stands at $214.0 million, including $50.0 million of punitive damages not covered by insurance, under appeal; USFHP payment litigation with the U.S. Government is ongoing.
Government payer concentration
Priority Partners depends on an annually renewed Maryland HealthChoice contract and Hopkins Health Advantage on an annual CMS contract; Medicare (27.3%) and Medicaid/Medicaid MCO (16.4%) are large shares of patient revenue.
Federal policy change
The One Big Beautiful Bill Act, enacted July 4, 2025, includes tax and regulatory changes whose impact JHHS will evaluate in fiscal 2026.

Where a supplier can help

Purchased services and outsourcing
Tied to the thin operating margin: purchased services are the single largest cost line, so suppliers that cut outsourced service or supply costs speak directly to the system's economics.
Revenue cycle and payer compliance
Tied to government payer concentration and the compliance risks: revenue-cycle, audit-readiness and coding tools help a system paid largely by Medicare, Medicaid and TRICARE.
Pharmacy operations
Tied to growing pharmacy revenue: specialty pharmacy, inventory and dispensing technology fit a business that grew to $786.5 million.
Research and campus facilities
Tied to the medical research building and campus capital spending: equipment, construction and facilities-management suppliers have a live programme through 2026.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Johns Hopkins Medicine?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Johns Hopkins Medicine

What is Johns Hopkins Medicine's health system?

The Johns Hopkins Health System Corporation is the not-for-profit parent of the clinical side of Johns Hopkins Medicine: six hospitals in Maryland, Washington, D.C. and Florida, physician groups, home care, pharmacies and the Johns Hopkins Health Plans.

What was the Johns Hopkins Health System's revenue in FY2025?

Total operating revenues and other support were $9,639.1 million in the year ended June 30, 2025, up from $9,047.9 million, with income from operations of $192.8 million.

How is the health system related to the Johns Hopkins University?

They are separate legal entities. The University's School of Medicine faculty provide clinical services and run research in JHHS hospitals, and JHHS paid the University $527.7 million for medical services in FY2025.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)